Sally C. Pipes: Safety kills when the FDA does too much

Published



Today, it takes a pharmaceutical company about 12 years to 15 years to develop a new drug and see it through the approval process of the Food and Drug Administration. All too often, as these breakthrough medicines slowly wind their way through the FDA’s bureaucratic maze, patients die while waiting for cures.

Development of the miracle drug Avastin started in 1989. Yet it wasn’t approved for the treatment of colon cancer until 2004. Who knows how many lives could have been saved in the intervening years?

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.